Vivos Therapeutics
VVOS
VVOS
20 hedge funds and large institutions have $2M invested in Vivos Therapeutics in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.04M | |
| 2 | +$163K | |
| 3 | +$68.7K | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$21.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.33K |
Top Sellers
| 1 | -$65.3K | |
| 2 | -$53.5K | |
| 3 | -$53.5K | |
| 4 |
Millennium Management
New York
|
-$31.3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.45K |